What happens when Earth’s resources run out? Well, if science fiction has taught us anything, it’s that humanity will seek a new and habitable planet somewhere in the cosmos on which to keep the species going in perpetuity. When that day comes, we’ll need a viable way to procreate and deliver children in the vastness of outer space.
Enter SpaceLife Origin, a one-of-a-kind tech company that is seeking to make it possible for humans to give birth in the vacuum of space by 2024, a goal titled “Mission Cradle.” While that is its ultimate goal, SpaceLife is also striving to become the first company to “safe-guard human ‘Seeds-of-Life’ in space [Mission Ark] by 2020 [and] make embryo conception in space feasible [Mission Lotus] by 2021,” according to its official website.
The gallery below offers a glimpse at the patent-pending “Ark” designs. Vials of human DNA will be protected within the radiation-shielded spheres that are to be kept on Earth and satellites surrounding the planet. SpaceLife Origin describes this as an insurance policy for the continuation of mankind in case a catastrophe hits and we need to leave in a hurry.
Red blood cells are amazing. They pick up oxygen from our lungs and carry it all over our body to keep us alive. The hemoglobin molecule in red blood cells transports oxygen by changing its shape in an all-or-nothing fashion. Four copies of the same protein in hemoglobin open and close like flower petals, structurally coupled to respond to each other. Using supercomputers, scientists are just starting to design proteins that self-assemble to combine and resemble life-giving molecules like hemoglobin. The scientists say their methods could be applied to useful technologies such as pharmaceutical targeting, artificial energy harvesting, ‘smart’ sensing and building materials, and more.
Hundreds of giant viruses that infect bacteria have been discovered. Some seem to deploy CRISPR – the system used for gene editing – to fight their hosts.
“If I can bring forward the defeat of aging even one day, I would have saved the lives of 110,000 people.” – Dr. Aubrey de Grey at EmTech Asia 2019.
The age-old quest for immortality was largely confined to the myths and legends of past civilizations until about just two decades back when telomerase, the active component for the gene that confers immortality to cells was successfully isolated in a science laboratory. That turned the tide on the entire conversation from whether aging could be treated, to how it could be treated.
Since then it has spawned a whole new medical field – ‘healthspan’ – where scientific research is conducted with the aim of extending healthy human lives for as long as hundreds and thousands of years, if not outright immortality. It is not surprising that the intensive research into anti-aging technologies has attracted financial backing from those who are interested in technological progress – the tech community, the likes of Google and even cryptocurrency tycoons such as Ethereum Founder, Vitalik Buterin, who donated $2.4 million worth of ether to the nonprofit foundation SENS Research Foundation, of which Dr Aubrey de Grey is the Chief Science Officer.
My mission is to drastically improve your life by sharing how you can quickly break bad habits and build and keep new healthy habits. I read the books and do all the research and share my findings with you in my YouTube videos! Not a bad deal, eh?
This video is a book review of Telomere Lengthening: Curing all diseases including cancer & aging by Dr. Bill Andrews and Jon Cornell.
Dr. Bill Andrews commented on this book review shorting after it was uploaded to YouTube. Here’s Dr. Andrews’ comment: Great Review Brent!!! And, yes, I would love to do an interview with you. And, yes, I am coming out with a new book soon. The most potent telomerase inducer, TAM818 (www.defytime.com) produces 16% of the amount of telomerase to stop telomere shortening. Gene Editing is different than Gene Therapy (also called Gene Delivery). In our Gene Therapy (www.libellagt.com) we are delivering (not editing) the telomerase gene to human cells. Liz Parrish did Gene Therapy, not Gene Editing, though she does have big plans of doing Gene Editing also in the future. My books are also available in other languages at www.defytime.com. The reason that I wrote both books is to answer all the questions that people ask me when I speak on stage. It’s not meant to be a matter of opinion that needs scientific support. That is because most of what I say is not controversial at all. It is all widely accepted by the scientific community. Adding references would have just made the book more technical than I wanted. Nevertheless, the one chapter on “Telomerase Does Not Cause Cancer” is controversial and so, not only did I provide references, I provided a link so readers could read the full text scientific peer reviewed studies. Other than that chapter both books should be considered just aids to help others explain the field. The fact that I didn’t include a biography of myself is because the book isn’t about me. I am not trying to promote myself. I am just trying to make the world aware of the field so that more people would take an interest in supporting it; whether it is my lab or others. For those that want to know more about me my bio can be found at https://www.sierrasci.com/bill-andrews-bio. I sure hope Warren Buffet, Warren Buffet’s friend, or Dr. Peter Attia hear this book review!!! Thanks Brent!!!!
A second male birth control pill succeeded in preliminary testing, suggesting that a new form of contraception may eventually exist.
The new pill, which works similarly to female contraception, passed initial safety tests and produced hormone responses consistent with effective birth control in 30 men, according to research presented by the Los Angeles Biomedical Research Institute and the University of Washington at the Endocrine Society’s annual meeting. (The study has not yet been published in a peer-reviewed journal.) It’s early days for the drug — which has not yet been submitted for approval by the Food and Drug Administration (FDA) — but co-principal investigator Dr. Christina Wang, lead researcher at LA BioMed, says it’s an important step toward effective, reversible male hormonal contraception.
“In females you have many, many methods. You have the pill, you have the patch, you have the vaginal ring, you have intrauterine devices, injections,” Wang says. “In men there is nothing that is like hormonal contraception. The standard is not equal for the genders.”
